These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 36103165)

  • 21. Late-gadolinium enhancement is common in older pediatric heart transplant recipients and is associated with lower ejection fraction.
    Lawson AA; Watanabe K; Griffin L; Laternser C; Markl M; Rigsby CK; Sojka M; Robinson JD; Husain N
    J Cardiovasc Magn Reson; 2023 Nov; 25(1):61. PubMed ID: 37932797
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myocardial damage detected by late gadolinium enhancement cardiovascular magnetic resonance is associated with subsequent hospitalization for heart failure.
    Wong TC; Piehler KM; Zareba KM; Lin K; Phrampus A; Patel A; Moon JC; Ugander M; Valeti U; Holtz JE; Fu B; Chang CC; Mathier M; Kellman P; Butler J; Gheorghiade M; Schelbert EB
    J Am Heart Assoc; 2013 Nov; 2(6):e000416. PubMed ID: 24249712
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High mass (>18g) of late gadolinium enhancement on CMR imaging is associated with major cardiac events on long-term outcome in patients with biopsy-proven extracardiac sarcoidosis.
    Agoston-Coldea L; Kouaho S; Sacre K; Dossier A; Escoubet B; Chillon S; Laissy JP; Rouzet F; Kutty S; Extramiana F; Leenhardt A; Borie R; Crestani B; Ou P
    Int J Cardiol; 2016 Nov; 222():950-956. PubMed ID: 27526366
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimal timing of follow-up cardiac magnetic resonance in patients with uncomplicated acute myocarditis.
    Pieroni M; Ciabatti M; Zocchi C; Tavanti V; Camporeale A; Saletti E; Fumagalli C; Venezia D; Lombardi M; Olivotto I; Bolognese L
    Int J Cardiol; 2024 Feb; 397():131603. PubMed ID: 37979787
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognosis evaluation of chronic inflammatory cardiomyopathy with ring-like late gadolinium enhancement.
    Wang H; Bo K; Gao Y; Zhou Z; Xu L
    ESC Heart Fail; 2023 Jun; 10(3):1735-1744. PubMed ID: 36843322
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence and Prognostic Impact of Septal Late Gadolinium Enhancement in Acute Myocarditis With or Without Preserved Left Ventricular Function.
    Imazio M; Angelico G; Andriani M; Lobetti-Bodoni L; Davini O; Giustetto C; Rinaldi M
    Am J Cardiol; 2018 Dec; 122(11):1955-1958. PubMed ID: 30266253
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiovascular Magnetic Resonance Imaging in Patients With Ibrutinib-Associated Cardiotoxicity.
    Buck B; Chum AP; Patel M; Carter R; Nawaz H; Yildiz V; Ruz P; Wiczer T; Rogers KA; Awan FT; Bhat S; Guha A; Kittai AS; Simonetti OP; Raman SV; Wallace G; Sanchez R; Bonsu JM; Gambril J; Haddad D; Mann J; Wei L; Kola-Kehinde O; Byrd JC; Woyach JA; Addison D
    JAMA Oncol; 2023 Apr; 9(4):552-555. PubMed ID: 36729480
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence and prognostic significance of left ventricular myocardial late gadolinium enhancement in severe aortic stenosis.
    Rajesh GN; Thottian JJ; Subramaniam G; Desabandhu V; Sajeev CG; Krishnan MN
    Indian Heart J; 2017; 69(6):742-750. PubMed ID: 29174252
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic value of cardiac magnetic resonance imaging parameters in left ventricular noncompaction with left ventricular dysfunction.
    Bai W; Xu R; Li X; Xu H; Fu H; Hou R; Zhou Z; Huang W; Wang Y; Guo Y
    BMC Cardiovasc Disord; 2022 Dec; 22(1):526. PubMed ID: 36474142
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Conductive channels identified with contrast-enhanced MR imaging predict ventricular tachycardia in systolic heart failure.
    Lin LY; Su MY; Chen JJ; Lai LP; Hwang JJ; Tseng CD; Chen YS; Yu HY; Tseng WY; Lin JL
    JACC Cardiovasc Imaging; 2013 Nov; 6(11):1152-9. PubMed ID: 24229767
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Feature Tracking Myocardial Strain Incrementally Improves Prognostication in Myocarditis Beyond Traditional CMR Imaging Features.
    Fischer K; Obrist SJ; Erne SA; Stark AW; Marggraf M; Kaneko K; Guensch DP; Huber AT; Greulich S; Aghayev A; Steigner M; Blankstein R; Kwong RY; Gräni C
    JACC Cardiovasc Imaging; 2020 Sep; 13(9):1891-1901. PubMed ID: 32682718
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic significance of late gadolinium enhancement quantification in cardiac magnetic resonance imaging of hypertrophic cardiomyopathy with systolic dysfunction.
    Funada A; Kanzaki H; Noguchi T; Morita Y; Sugano Y; Ohara T; Hasegawa T; Hashimura H; Ishibashi-Ueda H; Kitakaze M; Yasuda S; Ogawa H; Anzai T
    Heart Vessels; 2016 May; 31(5):758-70. PubMed ID: 25820658
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extracellular volume fraction improves risk-stratification for ventricular arrhythmias and sudden death in non-ischaemic cardiomyopathy.
    Di Marco A; Brown PF; Bradley J; Nucifora G; Anguera I; Miller CA; Schmitt M
    Eur Heart J Cardiovasc Imaging; 2023 Mar; 24(4):512-521. PubMed ID: 35877070
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Global longitudinal strain by CMR improves prognostic stratification in acute myocarditis presenting with normal LVEF.
    Porcari A; Merlo M; Baggio C; Gagno G; Cittar M; Barbati G; Paldino A; Castrichini M; Vitrella G; Pagnan L; Cannatà A; Andreis A; Cecere A; Cipriani A; Raafs A; Bromage DI; Rosmini S; Scott P; Sado D; Di Bella G; Nucifora G; Marra MP; Heymans S; Imazio M; Sinagra G
    Eur J Clin Invest; 2022 Oct; 52(10):e13815. PubMed ID: 35598175
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Right ventricular involvement and the extent of left ventricular enhancement with magnetic resonance predict adverse outcome in pulmonary sarcoidosis.
    Smedema JP; van Geuns RJ; Ector J; Heidbuchel H; Ainslie G; Crijns HJGM
    ESC Heart Fail; 2018 Feb; 5(1):157-171. PubMed ID: 28967698
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic Value of Late Gadolinium Enhancement in Nonischemic Cardiomyopathy.
    Gaztanaga J; Paruchuri V; Elias E; Wilner J; Islam S; Sawit S; Viles-Gonzalez J; Sanz J; Garcia MJ
    Am J Cardiol; 2016 Oct; 118(7):1063-8. PubMed ID: 27614850
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Late gadolinium enhancement in cardiac sarcoidosis: characteristic magnetic resonance findings and relationship with left ventricular function.
    Watanabe E; Kimura F; Nakajima T; Hiroe M; Kasai Y; Nagata M; Kawana M; Hagiwara N
    J Thorac Imaging; 2013 Jan; 28(1):60-6. PubMed ID: 23249970
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CMR quantification of myocardial scar provides additive prognostic information in nonischemic cardiomyopathy.
    Neilan TG; Coelho-Filho OR; Danik SB; Shah RV; Dodson JA; Verdini DJ; Tokuda M; Daly CA; Tedrow UB; Stevenson WG; Jerosch-Herold M; Ghoshhajra BB; Kwong RY
    JACC Cardiovasc Imaging; 2013 Sep; 6(9):944-54. PubMed ID: 23932642
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ischemic and non-ischemic patterns of late gadolinium enhancement in heart failure with reduced ejection fraction.
    Matusik PS; Bryll A; Matusik PT; Popiela TJ
    Cardiol J; 2021; 28(1):67-76. PubMed ID: 32037500
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extensive late gadolinium enhancement on cardiovascular magnetic resonance predicts adverse outcomes and lack of improvement in LV function after steroid therapy in cardiac sarcoidosis.
    Ise T; Hasegawa T; Morita Y; Yamada N; Funada A; Takahama H; Amaki M; Kanzaki H; Okamura H; Kamakura S; Shimizu W; Anzai T; Kitakaze M
    Heart; 2014 Aug; 100(15):1165-72. PubMed ID: 24829369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.